0001104659-20-109853.txt : 20200929 0001104659-20-109853.hdr.sgml : 20200929 20200929163024 ACCESSION NUMBER: 0001104659-20-109853 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20200929 FILED AS OF DATE: 20200929 DATE AS OF CHANGE: 20200929 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: RA CAPITAL MANAGEMENT, L.P. CENTRAL INDEX KEY: 0001346824 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-39539 FILM NUMBER: 201209204 BUSINESS ADDRESS: STREET 1: 200 BERKELEY STREET, 18TH FLOOR CITY: BOSTON STATE: MA ZIP: 02116 BUSINESS PHONE: 617-778-2500 MAIL ADDRESS: STREET 1: 200 BERKELEY STREET, 18TH FLOOR CITY: BOSTON STATE: MA ZIP: 02116 FORMER NAME: FORMER CONFORMED NAME: RA CAPITAL MANAGEMENT, LLC DATE OF NAME CHANGE: 20051213 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Kolchinsky Peter CENTRAL INDEX KEY: 0001384859 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-39539 FILM NUMBER: 201209205 MAIL ADDRESS: STREET 1: 200 BERKELEY STREET STREET 2: 18TH FLOOR CITY: BOSTON STATE: MA ZIP: 02116 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Shah Rajeev M. CENTRAL INDEX KEY: 0001619841 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-39539 FILM NUMBER: 201209206 MAIL ADDRESS: STREET 1: 200 BERKELEY STREET STREET 2: 18TH FLOOR CITY: BOSTON STATE: MA ZIP: 02116 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: PMV Pharmaceuticals, Inc. CENTRAL INDEX KEY: 0001699382 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 463218129 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 8 CLARKE DRIVE CITY: CRANBURY STATE: NJ ZIP: 08512 BUSINESS PHONE: (609) 642-6664 MAIL ADDRESS: STREET 1: 8 CLARKE DRIVE CITY: CRANBURY STATE: NJ ZIP: 08512 4 1 tm2032024-1_4.xml OWNERSHIP DOCUMENT X0306 4 2020-09-29 1 0001699382 PMV Pharmaceuticals, Inc. PMVP 0001346824 RA CAPITAL MANAGEMENT, L.P. 200 BERKELEY STREET 18TH FLOOR BOSTON MA 02116 0 0 1 0 0001384859 Kolchinsky Peter 200 BERKELEY STREET 18TH FLOOR BOSTON MA 02116 0 0 1 0 0001619841 Shah Rajeev M. 200 BERKELEY STREET 18TH FLOOR BOSTON MA 02116 0 0 1 0 Common Stock 2020-09-29 4 C 0 760265 A 760265 I See footnote Common Stock 2020-09-29 4 P 0 950000 18 A 1710265 I See footnote Series D Preferred Stock 2020-09-29 4 C 0 760265 0 D Common Stock 760265 0 I See footnote The shares of Series D Preferred Stock converted into Common Stock on a one to one basis immediately prior to the completion of the Issuer's initial public offering of Common Stock and have no expiration date. Includes (a) 513,885 shares held by RA Capital Healthcare Fund L.P. (the "Fund"), (b) 56,314 shares held in a separately managed account (the "Account") and (c) 190,066 shares held by RA Capital Nexus Fund, L.P. (the "Nexus Fund"). RA Capital Management, L.P. (the "Adviser") is the investment manager for the Fund, the Nexus Fund and the Account. The general partner of the Adviser is RA Capital Management GP, LLC (the "Adviser GP"), of which Dr. Peter Kolchinsky and Mr. Rajeev Shah are the managing members. The Adviser, the Adviser GP, Dr. Kolchinsky, and Mr. Shah may be deemed indirect beneficial owners of the reported securities for purposes of Section 13(d) of the Securities Exchange Act of 1934 (the "Act"). They disclaim beneficial ownership of any of the reported securities for the purpose of determining whether they are subject to Section 16 of the Act, however, in reliance on Rule 16a-1(a)(1)(v) and (vii). To the extent that they might be deemed subject to Section 16, they disclaim beneficial ownership of securities held by the Fund and the Nexus Fund for purposes of Rule 16a-1(a)(2), except to the extent of their pecuniary interest therein, and disclaim any pecuniary interest in securities held in the Account for purposes of Rule 16a-1(a)(2). Includes (a) 820,106 shares held by the Fund, (b) 81,669 shares held by the Account, and (c) 48,225 shares held by the Nexus Fund, in each case acquired in the Issuer's initial public offering. Includes (a) 1,333,991 shares held by the Fund, (b) 137,983 shares held by the Account, and (c) 238,291 shares held by the Nexus Fund. /s/ Peter Kolchinsky, Manager of RA Capital Management, L.P. 2020-09-29 /s/ Peter Kolchinsky, individually 2020-09-29 /s/ Rajeev Shah, individually 2020-09-29